We use U.S. cloud computing service providers that may be characterized as U.S. IaaS providers under the proposed regulations.
Summary · 第 38 页
Nevertheless, we have established relationships with several other leading cloud computing service providers in China, which are also competitive, competent and commonly used in the market according to Frost & Sullivan, and we can also engage other cloud computing service providers outside the U.S. and China.
As a third-party platform, we do not produce proprietary digital content and primarily rely on third-party content providers of online literature.
Summary · 第 1 页
We typically rely on third-party content providers to provide digital content and then distribute such content through our platform or other third-party web-based platforms as we do not produce proprietary digital content.
Financial Information · 第 371 页
We have fostered long-term business relationship with a number of digital content providers, such as online literature content providers and online game operators, to promote and recommend their digital content to suitable users.
In October 2019, we entered into a collaboration agreement (the “IBC0966 Agreement”) with ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (“ImmuneOnco”) with respect to the technology transfer, development, manufacture and commercialization of IBC0966.
Summary · 第 18 页
In exchange of our rights, we are obligated to pay RMB20.0 million assignment fee by installments.
Summary · 第 19 页
In addition, in the occurrence of pre-specified safety issues resulting in the aforementioned failure of IBC0966, we are entitled to a 50% payment return and ImmuneOnco is entitled to restitutions of the transferred rights and interests of IBC0966 upon the termination of the IBC0966 Agreement.
Our precision marketing services primarily rely on Supplier A, a leading Chinese internet technology company operating the largest short video distribution platform in terms of average DAUs in China in 2023.
Business · 第 296 页
Our gross spending with Supplier A amounted to RMB3,769.8 million, RMB4,591.6 million and RMB5,372.6 million in 2021, 2022 and 2023, respectively, accounting for 82.8%, 79.4% and 86.4% of our total gross spending for the respective years.
Business · 第 296 页
According to Frost & Sullivan, it is common in the online advertisement industry for media platforms not to enter into long-term supply agreements with an obligation to provide advertising traffic, and our arrangements with Supplier A are in line with industry practice.
The delay in the launch of new flagship products was primarily caused by the pandemic prevention policies under which transport of the testing machines used for the co-development projects among us, Semiconductor Corporation A and Technology Corporation A were hindered.
Summary · 第 13 页
Benefiting from our long-term strategic cooperation on multiple projects with international leading technology companies, such as Semiconductor Corporation A, our technical level and solution capabilities have been effectively improved.
TPV contribution from circumstances where we provide a mix of pay-in, pay-out and acquiring services to Chinese cross-border merchants, including circumstances where we provided pay-in and pay-out services only to cross-border merchants as well as circumstances where we provide acquiring, pay-in and pay-out services to cross-border merchants (independent site sellers), represented 96.4%, 93.6%, 87.2% and 78.7% of our total TPV of global payment services in 2020, 2021, 2022 and for the nine months ended September 30, 2023, respectively.
Summary · 第 7 页
Maintaining a healthy collaborative relationship with diverse global business partners is critical for us to offer differentiated services and to improve our operating results.
Financial Information · 第 387 页
In particular, we witnessed a substantial growth in the number of active customers in 2023, primarily due to our partnership with new e-commerce platforms that enabled us to acquire new customers.
In particular, Zhongmei Huadong shall be the Marketing Authorization Holder (“MAH”) of QX001S in China to exclusively conduct marketing activities and commercialization of QX001S, who shall make commercially reasonable efforts to promote such commercialization.
Summary · 第 17 页
As of the Latest Practicable Date, we had received the upfront payment and milestone payment in a total of RMB50 million from Zhongmei Huadong under the QX001S Framework Agreement.
Summary · 第 17 页
In order to ensure the successful launch of our first expected commercial drug, QX001S, we formed a strategic collaboration with an established pharmaceutical company, Huadong Medicine, which is experienced in chronic disease management and has strong sales networks for autoimmune and allergic drugs.
We entered into a technology transfer agreement with Joincare Pharmaceutical Group Industry Co., Ltd. (“Joincare”) in January 2024 (the “QX008N Agreement”), to grant Joincare an exclusive license of the know-how and patents controlled by us to develop, manufacture and commercialize QX008N in mainland China, Hong Kong and Macau.
Business · 第 344 页
Pursuant to the QX008N Agreement, Joincare will be responsible for the clinical development (including certain preclinical studies required for BLA approval), regulatory activities, manufacturing and commercialization of QX008N in the licensed territory at its own costs and expenses (other than a part of the Phase Ib clinical trial in China that we have already initiated).
Business · 第 344 页
As of the Latest Practicable Date, we had received the first upfront payment.
泛远国际控股集团有限公司FAR International Holdings Group Company Limited02516.HK
通过阿里国际站及Yidatong开展业务
During the Track Record Period, we conducted sales promotion on Alibaba.com. The revenue generated from our provision of services to Alibaba.com amounted to approximately RMB37.1 million, RMB218.6 million, RMB153.3 million, RMB86.9 million and RMB85.5 million, which represented approximately 2.5%, 16.1%, 12.2%, 14.3% and 12.7% of our total revenue for FY2020, FY2021, FY2022, 6M2022 and 6M2023, respectively.
Financial Information · 第 417 页
For FY2021, we conducted sales promotion on an e-commerce platform, Alibaba.com, through our business relationship with Yidatong, resulting in a gross loss of approximately RMB21.5 million in this sub-segment.
Financial Information · 第 418 页
primarily attributable to the reduction of the intensity and discounts offered in our sales promotion during FY2022
国鸿氢能科技（嘉兴）股份有限公司Sino-Synergy Hydrogen Energy Technology (Jiaxing) Co., Ltd.09663.HK
依赖Ballard Power技术授权及独家MEA供应
Pursuant to the original agreements we entered into with Ballard Power in 2016 and the amended and restated stack assembly license agreement and other auxiliary agreements we entered into with Ballard Power in 2019, Synergy Power obtained an exclusive license to assemble, sell and service the 9SSL fuel cell stacks in the PRC.
Business · 第 261 页
Pursuant to our joint venture agreements and a stack assembly license and technology transfer agreement with Ballard Power, Ballard Power provided technology transfer services (including the transfer of production technologies and know-hows), test equipment, production equipment specification, procurement services, training and commissioning support to us in relation to the establishment of the production line in Yunfu for the production of 9SSL fuel cell stacks, and we paid a consideration for this license and cooperation agreement while Ballard Power also became the exclusive supplier of MEAs used for the manufacturing of the 9SSL fuel cell stacks.
国鸿氢能科技（嘉兴）股份有限公司Sino-Synergy Hydrogen Energy Technology (Jiaxing) Co., Ltd.09663.HK
合作开发车型产生的收入占比最高达85.4%
For the years ended 31 December 2020, 2021, 2022 and the five months ended 31 May 2023, revenue generated from the sale of hydrogen fuel cell systems (excluding the additional components of hydrogen storage systems and batteries) for the hydrogen fuel cell vehicle models that we collaborated with the vehicle manufacturers to develop accounted for 48.3%, 78.7%, 64.3% and 85.4% of our total revenue, respectively.
Business · 第 267 页
Revenue from Zhizi Automotive, one of our five largest customers for the year ended 31 December 2022 and the five months ended 31 May 2023, contributed 34.3% and 31.4% of our revenue for the respective year/period, whereas Xiamen King Long, one of our five largest customers for the year ended 31 December 2021, contributed 20.9% of our revenue for the year ended 31 December 2021.
Our cooperation with the Media Partner is on a non-exclusive basis and is subject to renewal each year.
Summary · 第 6 页
For FY2022, we generated revenue of approximately RMB24.9 million from the provision of advertisement placement services (including rebates from Media Partner), which represented approximately 12.0% of our total revenue.
Summary · 第 7 页
Therefore, the amount of rebates to be earned by us is solely determined by the Media Partner with reference to the aforesaid industry classification set by them internally and was not subject to negotiation between the Media Partner and us.
For the years ended 31 December 2020, 2021, 2022 and the six months ended 30 June 2023, our revenue generated from e-hailing operating lease from customers sourced from Didi Group was RMB3.3 million, RMB56.2 million, RMB33.8 million and RMB10.5 million, accounted for 2.8%, 42.3%, 29.2% and 19.9% of our revenue from e-hailing operating lease business, respectively.
Business · 第 200 页
The Business Cooperation Agreement was terminated on 21 May 2021 with the mutual consent of the parties to the agreement as a result of changes in the regulatory environment such as promulgation of ''the Anti-Monopoly Guidelines of the Anti-Monopoly Committee of the State Council on Platform Economy'' on 7 February 2021 by the Anti-Monopoly Committee of the State Council (the ''Anti-Monopoly Guidelines'') targeting Internet platforms which signaled a strengthening of antitrust enforcement against monopolistic behaviours in China's Internet platform sector.
Business · 第 197 页
Under the Business Cooperation Agreement, we were not restricted from sourcing drivers through other channels, such as our own sales outlets or automobile agents for our e-hailing operating lease business.
In Southeast Asia, a majority of our parcels directly came from e-commerce platforms during the Track Record Period, who have significant influence over the choice of delivery companies for the goods sold on these platforms.
Business · 第 214 页
In China, substantially all of our parcels originated from through e-commerce platforms, whose merchants have decision power over the choice of delivery companies for the goods sold on the platforms during the Track Record Period.
Business · 第 214 页
In China, we expect to increase our parcel volume and market share through (i) deeper collaboration with existing e-commerce clients and expanding partnerships with more e-commerce platforms, (ii) improved and consistent service quality driven by optimized management of network partners, (iii) diversified sources of parcels from merchants on a wide range of e-commerce platforms, and (iv) continued efforts in developing non e-commerce customers to further diversify source of parcels.
十月稻田集团股份有限公司Shiyue Daotian Group Co., Ltd.09676.HK
线上渠道收入占比约七成且依赖电商平台
During the Track Record Period, our revenue generated from online channels was RMB1,849.5 million, RMB2,716.6 million, RMB3,144.2 million and RMB777.5 million in 2020, 2021, 2022 and the three months ended March 31, 2023, respectively, representing 79.4%, 75.5%, 69.3% and 71.9% of our total revenue in the respective periods.
Financial Information · 第 279 页
We generate a big portion of our revenue from our cooperation with certain e-commerce platforms.
Business · 第 207 页
We not only maintain strong partnerships with, and have established leading positions on, prominent comprehensive e-commerce platforms, but also proactively explore new cooperation opportunities in emerging channels such as social e-commerce platforms and community group buying platforms.
We rely on certain collaborating media platforms in promoting our games and in acquiring new users.
Summary · 第 13 页
We incurred approximately 58.3%, 87.8%, 84.5% and 83.8% of our total selling and marketing expenses for 2020, 2021, 2022 and the four months ended April 30, 2023, respectively, to promote the game products we market and operate via our top five collaborating media platforms in each year/period of the Track Record Period, and 30.2%, 52.3%, 53.8% and 51.0% of our total selling and marketing expenses for 2020, 2021, 2022 and the four months ended April 30, 2023, respectively, to the largest collaborating media platform.
Pursuant to our business arrangements with collaborating distribution channels, the percentage of gross billings withheld by and attributable to them generally ranged between 40% and 92% of the total gross billings during the Track Record Period.
Summary · 第 5 页
Pursuant to our business arrangements with Supplier C, the percentage of gross billings withheld by and attributable to it during the Track Record Period was approximately 50% of the total gross billings that end users paid for the relevant game products in which Supplier C is involved.
Business · 第 288 页
Our cooperation with the distribution platforms are on a non-exclusive basis.
On July 26, 2022 (the “Effective Date”), we entered into an asset transfer agreement (the “CMS Agreement”) with Shenzhen Kangzhe Vision Pharmaceutical Development Co., Ltd. (深圳市康哲維盛醫藥發展有限責任公司) (formerly known as Kangzhe Pharmaceutical Research and Development (Shenzhen) Limited (深圳康哲醫藥發展有限公司)) (“CMS Vision”), a wholly-owned subsidiary of China Medical System Holdings Limited (0867.HK) (together with its subsidiaries, the “CMS Group”), to transfer all of the rights and assets relating to Y400 to CMS Vision.
Summary · 第 23 页
In case of any disagreement that cannot be resolved by negotiations, CMS Vision shall have the final decision-making authority over all matters relating to the development, manufacturing and commercialization of Y400 in the Territory (as defined below).
Summary · 第 23 页
We have received the full upfront payment of US$5 million from CMS Vision.
Given the preclinical effects of the combination of CD47 and HER2 targeted therapies, this collaboration allows us to further expand IMM01's market in a cost-efficient manner by leveraging the funds and resources of Sunshine Guojian.
Business · 第 311 页
Sunshine Guojian has final decision-making authority with respect to all material matters in relation to the clinical studies, including but not limited to, the preparation and modification of the clinical trial protocols, of this combination therapy for selected indications.
Business · 第 312 页
We retain full rights to commercialize IMM01 worldwide.